First screening tests approved for tickborne parasite

March 7, 2018

(HealthDay)—The first set of blood screening tests for the tickborne parasite Babesia microti have been approved by the U.S. Food and Drug Administration.

Also dubbed B. microti, the parasite infects 1,000 to 2,000 people per year in the United States, the agency said in a news release. In addition to being carried by blacklegged or , the disease also can be transmitted via the blood, organs or tissue of an infected donor.

"While [the disease] babesiosis is both preventable and treatable, until today, there was no way to screen for infections amongst blood donors," said Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research.

Most people infected with the parasite don't develop symptoms and are never diagnosed, the FDA said. Some people develop flu-like symptoms, such as fever, headache and body aches.

For some people with weakened immune systems, however, the infection may become life-threatening, the agency added.

The set of tests, known as the Imugen Babesia microti Arrayed Fluorescent Immunoassay, are not meant to diagnose the disease, the FDA warned.

The tests are produced by the British pharma firm Oxford Immunotech. Results can only be produced at the company's facility in Norwood, Mass., the agency said.

Explore further: Screening cuts transfusion-transmitted babesiosis risk

More information: Visit the FDA to learn more.

Related Stories

Screening cuts transfusion-transmitted babesiosis risk

December 9, 2016
(HealthDay)—Screening for Babesia microti antibodies and DNA in blood-donation samples is associated with a reduction in the risk of transfusion-transmitted babesiosis, according to a study published in the Dec. 8 issue ...

Combination therapy cures tick-borne illness in mice

June 6, 2016
A novel combination therapy cures an emerging infectious disease, babesiosis, which is transmitted by the same ticks that transmit the agents of Lyme disease, said Yale researchers. This "radical" therapy not only clears ...

First test to detect Zika in blood donations approved

October 9, 2017
(HealthDay)—The cobas Zika test has been approved by the U.S. Food and Drug Administration—the first approved screening test to detect the Zika virus in blood donations.

Lyme disease enhances spread of emerging tick infection

December 29, 2014
Mice that are already infected with the pathogen that causes Lyme disease appear to facilitate the spread of a lesser-known but emerging disease, babesiosis, into new areas.

Tick-borne illness babesiosis a hazard for seniors: FDA

July 2, 2013
(HealthDay)—A tick-borne illness that can be severe or fatal among seniors, newborns and people with weakened immune systems is becoming more common in certain parts of the United States, federal health officials warn.

Recommended for you

First proof a synthesized antibiotic is capable of treating superbugs

March 23, 2018
A "game changing" new antibiotic which is capable of killing superbugs has been successfully synthesised and used to treat an infection for the first time—and could lead to the first new class of antibiotic drug in 30 years.

Scientists identify potential drug target in blood-feeding hookworms

March 22, 2018
In hookworms that infect and feed on the blood of mice, scientists have discovered a key step in blood digestion that can be targeted to disrupt the parasite's development and survival. These findings, published in PLOS Pathogens ...

Global burden of low back pain—a consequence of negligence and misinformation

March 21, 2018
A series of groundbreaking papers from Australian and international researchers in The Lancet, published today (22/3) warns that low back pain is a major health burden globally - across developed and developing nations - ...

Microscopic 'shuttles' transport enzyme from cells to trigger onset of kidney disease

March 21, 2018
A new study involving the University of Sheffield has identified a key culprit in the onset of kidney disease in a major marker for kidney disease development.

Metabolite therapy proves effective in treating C. difficile in mice

March 20, 2018
A team of UCLA researchers found that a metabolite therapy was effective in mice for treating a serious infection of the colon known as Clostridium difficile infection, or C. difficile.

Study of COPD patients has created a 'looking glass' into genome of pathogen

March 19, 2018
Decades of work on chronic obstructive pulmonary disease (COPD) at the University at Buffalo and the Veterans Affairs Western New York Healthcare System have yielded extraordinary information about the pathogen that does ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.